Latest news in cancer
Ivosidenib is approved by FDA for myelodysplastic syndromes
The Food and Drug Administration approved ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) for adult patients with relapsed or refractory myelodysplastic...
Neoadjuvant/ adjuvant pembrolizumab is approved by the FDA for resectable non-small cell lung cancer
The Food and Drug Administration approved pembrolizumab (Keytruda, Merck) with platinum-containing chemotherapy as neoadjuvant treatment, and with continuation...
Nivolumab is approved by the FDA for adjuvant treatment of Stage IIB/C melanoma
The Food and Drug Administration approved nivolumab (Opdivo, Bristol-Myers Squibb Company) for the adjuvant treatment of completely resected Stage IIB/C...
Encorafenib with binimetinib is approved by the FDA for treatment of metastatic non-small cell lung cancer with a BRAF V600E mutation
The Food and Drug Administration approved encorafenib (Braftovi, Array BioPharma Inc., a wholly owned subsidiary of Pfizer) with binimetinib (Mektovi, Array...
Bosutinib is approved by the FDA for pediatric patients with chronic myelogenous leukemia
The Food and Drug Administration approved bosutinib (Bosulif, Pfizer) for pediatric patients 1 year of age and older with chronic phase (CP) Ph+ chronic...
New and updated indications are approved by FDA for temozolomide under Project Renewal
The Food and Drug Administration (FDA) approved updated labeling for temozolomide (Temodar, Merck) under Project Renewal, an Oncology Center of Excellence...
Melphalan is approved by FDA as a liver-directed treatment for uveal melanoma
HEPZATO KIT (melphalan for Injection/Hepatic Delivery System, Delcath Systems, Inc.) was approved by the Food and Drug Administration as a liver-directed...
Elranatamab-bcmm receives accelerated approval by FDA for multiple myeloma
Elranatamab-bcmm (Elrexfio, Pfizer, Inc.) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager that was given accelerated approval by...
A Deep Dive into CAR T Cell Therapy: How Does It Work?
Discover the science behind CAR T Cell therapy treatment in India! Explore how this revolutionary treatment transforms your immune cells into cancer fighters....
Is CAR T-Cell Therapy Available In India?
Have you ever wondered if there is a powerful way to fight cancer? Now just imagine if one day you found a ray of hope in your fight against cancer, a...
Niraparib and abiraterone acetate plus prednisone is approved by FDA for BRCA-mutated metastatic castration-resistant prostate cancer
The Food and Drug Administration approved the fixed dose combination of niraparib and abiraterone acetate (Akeega, Janssen Biotech, Inc.), with prednisone, for...
Talquetamab-tgvs has received accelerated approval for relapsed or refractory multiple myeloma
The Food and Drug Administration granted accelerated approval to talquetamab-tgvs (Talvey, Janssen Biotech, Inc.) for adults with relapsed or refractory...
Need help? Our team is ready to assist you.
We wish a speedy recovery of your dear and near one.